Perrigo — which manufactures generic drugs, over-the-counter medications and baby formulas — confirmed the search Tuesday.
The DOJ is investigating several generic drugmakers, including Perrigo, for allegedly colluding to set prices artificially high, according to USA Today.
“As has been previously disclosed by a number of companies, the antitrust division has been looking at industrywide pricing practices,” Perrigo said in a statement. “The company is taking this investigation seriously and is cooperating with the appropriate authorities.”
More articles on supply chain:
The key to supply chain efficiency: Aligning clinical and supply chain staff
US drug spending to hit $610B by 2021: 4 report findings
Physicians prescribe fewer branded drugs when hospitals limit drug rep interactions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.